|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
5/22/17 Mazzo David J 4 Dir.,Off.² 1:4K Lisata Therapeutics, Inc. Toppan Merrill/FA
5/22/17 Losordo Douglas W 4 Officer² 1:4K Lisata Therapeutics, Inc. Toppan Merrill/FA
5/22/17 Talamo Joseph 4 Officer² 1:4K Lisata Therapeutics, Inc. Toppan Merrill/FA
5/22/17 Preti Robert A 4 Other² 1:5K Lisata Therapeutics, Inc. Toppan Merrill/FA
5/18/17 Brown Gregory B 4 Director² 1:5K Lisata Therapeutics, Inc. Toppan Merrill/FA
5/18/17 Traber Peter G 4 Director² 1:5K Lisata Therapeutics, Inc. Toppan Merrill/FA
5/18/17 Klosk Steven M 4 Director² 1:5K Lisata Therapeutics, Inc. Toppan Merrill/FA
5/18/17 Myers Steven S 4 Dir.,Other² 1:7K Lisata Therapeutics, Inc. Toppan Merrill/FA
5/18/17 Lisata Therapeutics, Inc. 8-K:2,9 5/18/17 1:34K
____________ | ¹ | Filing/Form Types: | | 4 | Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }. | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. |
|